Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-10-24-Speech-2-060"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20061024.5.2-060"2
lpv:hasSubsequent
lpv:speaker
lpv:spoken text
"Madam President, I should like to thank Members for a very interesting and helpful debate. I knew from the beginning that we were on the same side, but it is good to reassure each other whenever possible. I should like to respond to a few specific points very briefly and then make one general comment, which will cover the issue raised. We are aware of the issue of breast cancer in men, raised by Mr Bowis. We have to deal with it as a rare disease, because it is much less common than for women. We are focusing on it and will raise it with experts very soon to see how we can include it in future guidelines, but as a rare disease, in the same way as we deal with other rare diseases. On research, I should like to repeat that environmental causes are part of the plan. The new Seventh Framework Programme will provide an opportunity to open up that area of research. Gene-environment interaction and cancer development will also cover lifestyle and other major risk factors. We will then be able to learn more about the causes of the disease. That is a priority, because prevention is much more important than having to treat the disease afterwards. The question of other cancers was raised by Mr Adamou. We are working on those and not just concentrating on one. Each one is a specific case and needs specific guidelines and a specific approach. We expect to have guidelines for cervical cancer by next year, for prostate cancer by 2008 and for colorectal cancer by 2009. We have to evaluate, we have to have research, we have to put everything together and then come up with guidelines. We are also working on other areas such as the hepatitis B and C viruses, because we know they cause liver cancer, as well as aspects such as tobacco, obesity and other causes of cancer. We have issued guidelines and recommendations on how Member States deal with this and the inequalities. These do not have legal force, so we cannot enforce them on Member States. They represent best practice. With your help, we encourage and put pressure on Member States to comply with the guidelines. I look forward to debating this once we have produced the report. We shall then be able to discuss the outcome and the commitment of the Member States. This is a worrying issue. The numbers are terrifying. If we have to put pressure on Member States to do their job on this, you can imagine what happens with rare diseases which do not affect so many people. Putting it cynically and bluntly, there is not so much political pressure. If we stop to think about it we could panic, but we must not. Our job is to make sure that Member States fulfil their commitments and follow the recommendations they adopt and the guidelines they agree to. We shall be working on that, in relation not just to breast cancer but to all the inequalities that unfortunately still exist in the European Union, within Member States as well as between Member States. This is not the European Union of solidarity that we all aspire to and have all joined. That applies to the use of structural funds. The money is there, but unless spending on health is adopted as a priority by Member States, there is nothing we can do. Again, it is a challenge for us to make Member States adopt the policies. Unless Member States acknowledge that spending on health is not a cost but an investment – and we have to convince them of that – the situation will not improve. That is where we have to work together and cooperate."@en1
lpv:unclassifiedMetadata

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz

The resource appears as object in 2 triples

Context graph